Health Jan 11 Investigation raises concerns about lack of FDA quality testing for generic drugs By John Yang, Andrew Corkery
Health Nov 23 What to know about menopause hormone therapy after FDA removed 'black box' warnings The FDA removed safety warnings from several hormone drugs used to treat menopause symptoms. Here’s what you need to know about these treatments before your next doctor's appointment. By Grace Abels, PolitiFact
Health Nov 19 What are biologics and can the Trump administration make them cheaper with biosimilars? Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s total prescription medicine spending, according to health data analysis company IQVIA. The Trump administration said it hopes to… By Madison Czopek, PolitiFact
Politics Nov 10 WATCH: RFK Jr. says FDA will remove long-standing warning from hormone-based menopause drugs The change announced Monday is a break from more than 20 years of FDA policy, in which the drugs carried the agency's most severe warning label. By Matthew Perrone, Associated Press
Health Nov 09 What to know about the FDA's recall of the blood pressure drug prazosin A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines. By C. Michael White, The Conversation
Oct 29 WATCH: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals By Tom Murphy, Matthew Perrone, Associated Press Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers. Continue reading
Oct 03 WATCH: FDA and HHS not endorsing generic abortion pill they just approved, White House says By Associated Press The White House said Friday that the Food and Drug Administration’s approval of a generic form of mifepristone was just following the law and not a sign of support for the abortion pill. Continue reading
Oct 02 FDA approves another generic abortion pill, prompting conservative backlash By Matthew Perrone, Associated Press Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration. Continue reading
Sep 24 What to know about leucovorin, unproven autism drug touted by Trump By Matthew Perrone, Associated Press When President Donald Trump’s administration announced it would repurpose an old, generic drug as a new treatment for autism, it came as a surprise to many experts — including the physician who suggested the idea to the nation’s top health… Continue reading
Sep 17 FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes By Matthew Perrone, Associated Press The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which has built a multibillion-dollar business centered around lower-cost versions of blockbuster obesity injections. Continue reading